Novo Nordisk A/S (NONOF)
OTCMKTS
· Delayed Price · Currency is USD
69.50
+0.20 (0.29%)
Mar 31, 2025, 3:51 PM EST
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$524,749
Profits / Employee
$182,482
Market Cap
305.46B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Novo Nordisk News
- 4 hours ago - Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha
- 1 day ago - Novo Nordisk: Finally A Buying Opportunity - Seeking Alpha
- 1 day ago - Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors - Seeking Alpha
- 1 day ago - Novo Nordisk (NVO) Q1 2025 Earnings May Fall Short of Expectations - GuruFocus
- 1 day ago - NVO: Novo Nordisk Shows Impressive Growth as Top ADR Stock - GuruFocus
- 1 day ago - Novo Nordisk (NVO) Outperforms Market Amid Recent Downturn - GuruFocus
- 2 days ago - Novo Nordisk (NVO) Reports Positive Results in Ozempic Phase 3b Trial for PAD - GuruFocus
- 2 days ago - Novo Nordisk's Ozempic (NVO) Shows Promise in PAD and Type 2 Diabetes Treatment - GuruFocus